- Adults
- Elderly
- Fragile population
- Immunocompromised host
- Hospital wide
- Outpatient clinic
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Monoclonal antibodies
- Sotrovimab
- Tixagevimab/Cilgavimab
- Casirivimab/Imdevimab
Population: Immunocompromised host
An individual with an impaired immune system due to conditions such as HIV, cancer, organ transplantation, or immunosuppressive therapy
- Adults
- Elderly
- Fragile population
- Immunocompromised host
- Hospital wide
- Emergency department
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Remdesivir
- Nirmatrelvir/Ritonavir
- Fragile population
- Immunocompromised host
- SARS-CoV-2
- Post-COVID-19
- Adults
- Fragile population
- Immunocompromised host
- People at high risk of STIs
- People living with HIV
- PrEP users
- Non-hospital health centre
- Telemedicine
- Monkeypox virus
- Monkeypox virus infection
- Pharmacological intervention
- Vaccination
- Adults
- Elderly
- Fragile population
- Immunocompromised host
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Monoclonal antibodies
- AZD3152
- Adults
- Fragile population
- Immunocompromised host
- People at high risk of STIs
- People living with HIV
- PrEP users
- Hospital wide
- Outpatient clinic
- Infectious diseases unit
- Monkeypox virus
- Monkeypox virus infection
- Adults
- Fragile population
- Immunocompromised host
- People at high risk of STIs
- People living with HIV
- PrEP users
- Outpatient clinic
- Non-hospital health centre
- STD/STI clinic
- Monkeypox virus
- Monkeypox virus infection
- Adults
- Fragile population
- Immunocompromised host
- People at high risk of STIs
- Men who have sex with men
- People living with HIV
- Hospital wide
- Monkeypox virus
- Monkeypox virus infection
- Adults
- Elderly
- Fragile population
- Immunocompromised host
- Hospital wide
- Outpatient clinic
- SARS-CoV-2
- Acute SARS-CoV-2
- Adults
- Fragile population
- Immunocompromised host
- People living with HIV
- Hospital wide
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Adults
- Elderly
- Fragile population
- Paediatric
- Immunocompromised host
- Outpatient clinic
- Non-hospital health centre
- Community
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Monoclonal antibodies
- Sotrovimab
- Adults
- Elderly
- Fragile population
- Immunocompromised host
- Hospital wide
- Outpatient clinic
- SARS-CoV-2
- Acute SARS-CoV-2
- Non pharmacological intervention
- Convalescent plasma